Protocol Ledger

Federal / Public Agency · Consolidated Sponsor Hub

Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus: Clinical Trials & FDA Approval Profile

Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus (Global / Institutional) sponsors 18 reconciled interventional Phase II and Phase III ClinicalTrials.gov studies (2018 to 2026), including 0 active protocols (0 recruiting now), 9 completed protocols, and 0 all-time original FDA Drugs@FDA NDA and BLA approvals.

Track in Studio / Generate Client Brief ->
Early-Stop Rate vs National (13.8%)0.0%
Median Closed Enrollment vs National (145 pts)10 participants

Verified Sponsor Execution & Regulatory Ledger

Reconciled ClinicalTrials.gov v2 & Drugs@FDA Metrics for Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus
Sponsor MetricVerified Count / Rate
Phase II & III Protocols (2018 to 2026)18
Active Pipeline (Recruiting Now)0 (0)
Completed vs Stopped Early9 / 0 (0.0%)
Median Closed Actual Enrollment10 participants
Physical Hospital Site Disclosure100.0% named hospitals
FDA Drugs@FDA Original NDA/BLA Approvals0 (0 since 2018)

Explore interactive annual charts and M&A subsidiary rollups in the Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus Interactive Dossier, benchmark peers in Rare Genetic, Women's Health, and Other, or review the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI